Caredx launches personalized allohome patient monitoring solution to augment pre- and post-transplant care

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the availability of allohome™, a pan-organ patient monitoring solution that extends care into a patient's home by capturing a range of vital health data that can help doctors with the early identification of adverse clinical event
CDNA Ratings Summary
CDNA Quant Ranking